SCHEMBL8170812

SCHEMBL8170812

O=S(=O)(CCC1CCNCC1)c1ccccc1Br

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CHRM1 P11229 1/20 0.57
▸ CHRM3 P20309 1/20 0.57
▸ PLCG1 P19174 1/20 0.49
▸ MAPT P10636 1/20 0.40
▸ CA1 P00915 1/20 0.40
▸ CA2 P00918 1/20 0.40
▸ CA4 P22748 1/20 0.40
▸ CA6 P23280 1/20 0.40
▸ GBA1 P04062 1/20 0.39
▸ SLC6A4 P31645 2/20 0.37
▸ HTR6 P50406 4/20 0.36
▸ KDM1A O60341 1/20 0.36
▸ MAOA P21397 1/20 0.36
▸ MAOB P27338 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ ATM Q13315 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8558248 0.92 CHRM1 (0.52) CHRM1CHRM3PLCG1MAPTCA1
SCHEMBL8557186 0.74 CHRM1 (0.49) CHRM1CHRM3SLC6A4HTR6KDM1A
SCHEMBL15916256 0.73 PLCG1 (0.60) PLCG1MAPTCA1CA2CA4
SCHEMBL6469248 0.71 CHRM1 (0.45) CHRM1CHRM3CA2GBA1SLC6A4
SCHEMBL6011594 0.70 CRBN (0.46) CHRM1CHRM3KMT2A
SCHEMBL8555011 0.70 ALDH1A1 (0.51) CHRM1CHRM3MAPTHTR6KDM1A
SCHEMBL6011463 0.70 CHRM1 (0.44) CHRM1CHRM3CA1CA2CA4
SCHEMBL6011372 0.70 CHRM1 (0.44) CHRM1CHRM3CA2KDM1AKMT2A
SCHEMBL15917691 0.70 MAPT (0.74) PLCG1MAPTCA1CA2CA4
SCHEMBL6469254 0.70 CHRM1 (0.44) CHRM1CHRM3CA1CA2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6114328-A ANTICOAGULANTS; BLOOD DISORDERS DUPONT PHARMACEUTICALS COMPANY (US) 2000-09-05 — — US disclosed
US-5849736-A Isoxazoline and isoxazole fibrinogen receptor antagonists THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1998-12-15 — — US disclosed
EP-0832076-A1 NOVEL ISOXAZOLINE AND ISOXAZOLE FIBRINOGEN RECEPTOR ANTAGONISTS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1998-04-01 — — EP disclosed
Send feedback